| Erector Spinae Plane Block in Scoliotic Adolescents (NCT03968146) | Kasr El Aini Hospital | 2019-06-18 |
| A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL (NCT04438044) | Beijing InnoCare Pharma Tech Co., Ltd. | 2019-06-18 |
| Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer (NCT04126525) | RenJi Hospital | 2019-06-18 |
| Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B (NCT03995784) | Catalyst Biosciences | 2019-06-18 |
| Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial (NCT03923933) | Hospital General de México Dr. Eduardo Liceaga | 2019-06-18 |
| A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage (NCT03987451) | Novo Nordisk A/S | 2019-06-18 |
| Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury (NCT03995732) | Beijing Tide Pharmaceutical Co., Ltd | 2019-06-18 |
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor (NCT04023721) | F-star Therapeutics, Inc. | 2019-06-18 |
| Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer (NCT04113863) | Mario Negri Institute for Pharmacological Research | 2019-06-18 |
| Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients (NCT03895437) | Tolerion, Inc. | 2019-06-17 |
| KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer (NCT03925974) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2019-06-17 |
| Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients (NCT03969017) | Sun Yat-sen University | 2019-06-17 |
| Dual bNAb Treatment in Children (NCT03707977) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-06-17 |
| Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS) (NCT03888924) | S. Andrea Hospital | 2019-06-17 |
| Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel (NCT03666832) | Joon Oh Park | 2019-06-17 |
| Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma (NCT04248387) | Fudan University | 2019-06-17 |
| A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery (NCT03891524) | Janssen Research & Development, LLC | 2019-06-17 |
| A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma (NCT03829254) | NuCana plc | 2019-06-17 |
| Preoperative Nerve Block for Rhinoplasty/Septoplasty (NCT03780478) | University of Southern California | 2019-06-17 |
| VAC 072-An Efficacy Study of R21/MM in Different Dose Schedules (NCT03970993) | University of Oxford | 2019-06-17 |
| Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma (NCT03604978) | National Cancer Institute (NCI) | 2019-06-17 |
| Urinary Track Infection Prevention After Urogynecological Surgery (NCT03818321) | TriHealth Inc. | 2019-06-17 |
| Vidofludimus Calcium for Primary Sclerosing Cholangitis (NCT03722576) | Elizabeth Carey | 2019-06-17 |
| Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin (NCT03736720) | Roswell Park Cancer Institute | 2019-06-17 |
| Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer (NCT03944941) | Alliance for Clinical Trials in Oncology | 2019-06-17 |
| Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery (NCT03856164) | University of Texas Southwestern Medical Center | 2019-06-17 |
| LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) (NCT03946527) | Antonio Fojo | 2019-06-17 |
| The Efficacy and Safety of Vitamin E Mixed Tocotrienols In Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT04140136) | University of Malaya | 2019-06-17 |
| The Efficacy of Graminex® Flower Pollen Extracts in Healthy Women With Urinary Incontinence (NCT05510999) | Graminex LLC | 2019-06-17 |
| Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis (NCT03954158) | Pfizer | 2019-06-15 |
| Conscious Sedation for Outpatient Colonoscopy (NCT03925779) | Menoufia University | 2019-06-15 |
| Early Communication Intervention for Toddlers With Hearing Loss (NCT03803943) | Northwestern University | 2019-06-15 |
| Deep Brain Stimulation for Treatment Resistant Depression (NCT04009928) | Sunnybrook Health Sciences Centre | 2019-06-15 |
| Sphingosine-1-phosphate and Pneumonia (NCT04007328) | Taipei Medical University WanFang Hospital | 2019-06-15 |
| Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults (NCT03942406) | ILiAD Biotechnologies | 2019-06-15 |
| Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System (NCT03495960) | International Extranodal Lymphoma Study Group (IELSG) | 2019-06-15 |
| Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. (NCT03283384) | Borstkanker Onderzoek Groep | 2019-06-15 |
| Thermal Ablation Followed by Immunotherapy for HCC (NCT03864211) | Xiangya Hospital of Central South University | 2019-06-15 |
| Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma (NCT03908372) | Chinese Academy of Medical Sciences | 2019-06-15 |
| Rifaximin in Patients With Diabetic Gastroparesis (NCT04254549) | Mayo Clinic | 2019-06-14 |
| Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT04054167) | M.D. Anderson Cancer Center | 2019-06-14 |
| Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer (NCT04017650) | M.D. Anderson Cancer Center | 2019-06-14 |
| Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer (NCT03768531) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-06-14 |
| Adjuvant Palbociclib in Elderly Patients With Breast Cancer (NCT03609047) | European Organisation for Research and Treatment of Cancer - EORTC | 2019-06-14 |
| Ultrasound-Guided Treatments for Shoulder Pain in Wheelchair Users With Spinal Cord Injury (NCT04136743) | Kessler Foundation | 2019-06-14 |
| A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers (NCT04761744) | Korean Cancer Study Group | 2019-06-14 |
| Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women (NCT03951194) | Genesis Athens Clinic | 2019-06-13 |
| A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis (NCT03963401) | Pfizer | 2019-06-13 |
| Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers (NCT04106843) | M.D. Anderson Cancer Center | 2019-06-13 |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors (NCT03899792) | Eli Lilly and Company | 2019-06-13 |
| Denosumab Treatment for Fibrous Dysplasia (NCT03571191) | National Institute of Dental and Craniofacial Research (NIDCR) | 2019-06-13 |
| Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2) (NCT03674242) | ERYtech Pharma | 2019-06-13 |
| The Role of Estrogen in the Neurobiology of Eating Disorders (NCT03740204) | Massachusetts General Hospital | 2019-06-13 |
| RECONsolidation of Traumatic Memories to ResOLve Post Traumatic Stress Disorder (RECONTROLPTSD) (NCT03827057) | Uniformed Services University of the Health Sciences | 2019-06-12 |
| An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia (NCT03989947) | BioMarin Pharmaceutical | 2019-06-12 |
| H+ Mobilization With Dialysate Bicarbonate Variation (NCT04020757) | Tufts Medical Center | 2019-06-12 |
| A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma (NCT04337931) | Apexigen America, Inc. | 2019-06-12 |
| Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM (NCT03927313) | University of Cape Town | 2019-06-12 |
| CCR5-modified CD4+ T Cells for HIV Infection (NCT03666871) | University of Cincinnati | 2019-06-12 |
| Window of Opportunity Study in Colorectal Cancer (NCT03984578) | National Cancer Centre, Singapore | 2019-06-12 |
| Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis (NCT03863574) | Zydus Therapeutics Inc. | 2019-06-12 |
| Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer (NCT03977233) | UNC Lineberger Comprehensive Cancer Center | 2019-06-12 |
| Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma (NCT03841201) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2019-06-12 |
| A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma (NCT03999749) | NYU Langone Health | 2019-06-11 |
| A Comparative Pharmacokinetic and Pharmacodynamic Study of Sildenafil in Adult Smokers and Non Smokers (NCT04100759) | Ain Shams University | 2019-06-11 |
| Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer (NCT03894891) | Dana-Farber Cancer Institute | 2019-06-11 |
| Hypofractionated Radiotherapy for Soft Tissue Sarcomas (NCT03972930) | University of Wisconsin, Madison | 2019-06-11 |
| Study of Jitongning Tablet to Treat Spondyloarthritis (NCT03932019) | Tasly Pharmaceutical Group Co., Ltd | 2019-06-11 |
| Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-associated Malignancies (NCT03988582) | Memorial Sloan Kettering Cancer Center | 2019-06-11 |
| Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant Melanoma (NCT03991975) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-06-11 |
| Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer (NCT03995667) | OHSU Knight Cancer Institute | 2019-06-11 |
| CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma (NCT04089215) | Shanghai Ming Ju Biotechnology Co., Ltd. | 2019-06-11 |
| Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer (NCT03822468) | Novartis Pharmaceuticals | 2019-06-11 |
| Hydroxyurea Therapy: Optimizing Access in Pediatric Populations Everywhere (NCT03825341) | St. Jude Children's Research Hospital | 2019-06-10 |
| Gene Therapy Clinical Study in Adult PKU (NCT03952156) | Homology Medicines, Inc | 2019-06-10 |
| Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy (NCT03948477) | University of Auckland, New Zealand | 2019-06-10 |
| Cardiovascular Effects of Racemic Epinephrine Pellets (NCT04688346) | University of Washington | 2019-06-10 |
| The SOLID Platelet Study (NCT03712618) | National Institutes of Health Clinical Center (CC) | 2019-06-10 |
| Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1) (NCT03975907) | CARsgen Therapeutics Co., Ltd. | 2019-06-10 |
| The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation (NCT03887377) | Henry Ford Health System | 2019-06-10 |
| Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients (NCT04137185) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2019-06-10 |
| Treatment of NF1-related Plexiform Neurofibroma With Trametinib (NCT03741101) | Region Skane | 2019-06-10 |
| Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients (NCT03971383) | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 2019-06-10 |
| ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects (NCT03687632) | Noveome Biotherapeutics, formerly Stemnion | 2019-06-10 |
| Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL (NCT03572634) | Sumitomo Pharma America, Inc. | 2019-06-10 |
| Effect of Nutritional Counseling Associated With Transcranial Direct-current Stimulation in Binge Eating Reduction (NCT04226794) | Hospital de Clinicas de Porto Alegre | 2019-06-10 |
| Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC) (NCT04052152) | The First Affiliated Hospital with Nanjing Medical University | 2019-06-10 |
| Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease (NCT03977584) | Hoffmann-La Roche | 2019-06-10 |
| Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial (NCT03978767) | Washington University School of Medicine | 2019-06-10 |
| Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients (NCT03913234) | Yonsei University | 2019-06-10 |
| A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye (NCT03982368) | Dompé Farmaceutici S.p.A | 2019-06-10 |
| Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors (NCT03911557) | John L. Villano, MD, PhD | 2019-06-08 |
| Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations (NCT03839342) | University Health Network, Toronto | 2019-06-07 |
| Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis (NCT04056897) | Biocad | 2019-06-07 |
| N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease) (NCT03759665) | IntraBio Inc | 2019-06-07 |
| Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy. (NCT03627988) | Institut Claudius Regaud | 2019-06-07 |
| Vopratelimab and a CTLA-4 Inhibitor in PD-1/PD-L1 Inhibitor Experienced Subjects With NSCLC or Urothelial Cancer (NCT03989362) | Jounce Therapeutics, Inc. | 2019-06-06 |
| A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH (NCT04006145) | Albireo | 2019-06-06 |
| Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia (NCT03844997) | Sudipto Mukherjee, MD, PhD, MPH | 2019-06-06 |
| Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome (NCT03779711) | Timothy J Nelson, MD, PhD | 2019-06-06 |